URETHRAL CANCER METASTATIC

URETHRAL CANCER METASTATIC was reported 16 times

URETHRAL CANCER METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Phenothiazine [EPC] 1 0.0000
1 Nicotinic Acid [EPC] 1 0.0000
2 Microtubule Inhibitor [EPC] 2 0.0000
3 Integrin Receptor Antagonist [EPC] 1 0.0000
4 Platinum-based Drug [EPC] 3 0.0000
5 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
6 5-alpha Reductase Inhibitor [EPC] 1 0.0000
7 Parathyroid Hormone Analog [EPC] 1 0.0000
8 Calcium [EPC] 1 0.0000
9 Mood Stabilizer [EPC] 1 0.0000
10 Anti-epileptic Agent [EPC] 1 0.0000
11 Alkylating Drug [EPC] 1 0.0000
12 Platelet Aggregation Inhibitor [EPC] 2 0.0000
13 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
14 GLP-1 Receptor Agonist [EPC] 1 0.0000
15 Kinase Inhibitor [EPC] 1 0.0000
16 Proton Pump Inhibitor [EPC] 1 0.0000
17 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
18 Benzodiazepine [EPC] 1 0.0000
19 Corticosteroid [EPC] 1 0.0000